LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 41 filers reported holding LUMOS PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $51,393 | -22.5% | 15,564 | -22.5% | 0.00% | – |
Q2 2023 | $66,328 | -2.6% | 20,089 | 0.0% | 0.00% | – |
Q1 2023 | $68,081 | +90674.7% | 20,089 | -3.1% | 0.00% | – |
Q4 2022 | $75 | -100.0% | 20,731 | 0.0% | 0.00% | – |
Q3 2022 | $184,000 | +15.0% | 20,731 | 0.0% | 0.00% | – |
Q2 2022 | $160,000 | -18.4% | 20,731 | 0.0% | 0.00% | – |
Q1 2022 | $196,000 | +36.1% | 20,731 | 0.0% | 0.00% | – |
Q4 2021 | $144,000 | -27.6% | 20,731 | -1.1% | 0.00% | – |
Q3 2021 | $199,000 | -49.2% | 20,953 | -46.8% | 0.00% | – |
Q2 2021 | $392,000 | -19.2% | 39,405 | -5.0% | 0.00% | – |
Q1 2021 | $485,000 | -68.8% | 41,459 | -4.8% | 0.00% | -100.0% |
Q4 2020 | $1,555,000 | +157.0% | 43,548 | -0.5% | 0.00% | – |
Q3 2020 | $605,000 | -10.8% | 43,763 | +6.5% | 0.00% | – |
Q2 2020 | $678,000 | +131.4% | 41,095 | +19.1% | 0.00% | – |
Q1 2020 | $293,000 | – | 34,499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 407,192 | $5,627,000 | 1.23% |
Opaleye Management Inc. | 240,892 | $3,329,000 | 0.65% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $12,940,000 | 0.32% |
NEA Management Company, LLC | 526,663 | $7,278,000 | 0.31% |
Investors Financial Group, LLC | 21,766 | $301,000 | 0.22% |
Wealth Advisors of Iowa, LLC | 11,760 | $163,000 | 0.11% |
Blackstone Inc. | 468,145 | $6,470,000 | 0.02% |
Jefferies Group LLC | 120,651 | $1,667,000 | 0.02% |
Texas Yale Capital Corp. | 16,000 | $221,000 | 0.02% |
Prospera Financial Services Inc | 1,088 | $15,000 | 0.01% |